# Misoprostol Dosing in BMI Greater Than 30

> **NCT05262738** · PHASE4 · COMPLETED · sponsor: **University of Texas at Austin** · enrollment: 180 (actual)

## Conditions studied

- Pregnancy Related
- Obesity
- Labor Onset and Length Abnormalities

## Interventions

- **DRUG:** 50 Micrograms Vaginal Misoprostol (Intervention)
- **DRUG:** 25 Micrograms Vaginal Misoprostol (Control)

## Key facts

- **NCT ID:** NCT05262738
- **Lead sponsor:** University of Texas at Austin
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-06-01
- **Primary completion:** 2023-07-14
- **Final completion:** 2023-07-17
- **Target enrollment:** 180 (ACTUAL)
- **Last updated:** 2024-07-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05262738

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05262738, "Misoprostol Dosing in BMI Greater Than 30". Retrieved via AI Analytics 2026-09-17 from https://api.ai-analytics.org/clinical/NCT05262738. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*